QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
QQQ   380.00 (+0.23%)
AAPL   148.85 (-0.31%)
MSFT   323.17 (+4.21%)
FB   312.22 (-1.14%)
GOOGL   2,924.35 (+4.96%)
TSLA   1,037.86 (+1.91%)
AMZN   3,392.49 (+0.49%)
NVDA   244.51 (-1.08%)
BABA   169.23 (-0.45%)
NIO   39.31 (-2.87%)
CGC   12.78 (-2.96%)
GE   103.85 (-3.34%)
AMD   122.28 (-0.53%)
MU   68.24 (-1.02%)
T   25.06 (-1.22%)
F   15.51 (-2.70%)
ACB   6.84 (-2.70%)
DIS   169.55 (-1.45%)
PFE   42.97 (-1.35%)
BA   206.61 (-1.53%)
AMC   34.76 (-3.58%)
NASDAQ:AMGN

Amgen Short Interest Ratio and Short Volume

$206.58
-2.10 (-1.01 %)
(As of 10/27/2021 04:00 PM ET)
Add
Compare
Today's Range
$205.81
$210.40
50-Day Range
$201.89
$231.20
52-Week Range
$200.47
$276.69
Volume
2.00 million shs
Average Volume
2.59 million shs
Market Capitalization
$117.31 billion
P/E Ratio
21.02
Dividend Yield
3.37%
Beta
0.68

Amgen (NASDAQ:AMGN) Short Interest Data

Current Short Volume
11,380,000 shares
Previous Short Volume
11,080,000 shares
Change Vs. Previous Month
+2.71%
Dollar Volume Sold Short
$2.37 billion
Short Interest Ratio / Days to Cover
4.5
Last Record Date
October, 15 2021
Outstanding Shares
567,852,000 shares
Float Size
566,690,000 shares
Short Percent of Float
2.01%
Today's Trading Volume
2,002,917 shares
Average Trading Volume
2,590,012 shares
Today's Volume Vs. Average
-22.67%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Amgen ?

Sign up to receive the latest short interest report for Amgen and its competitors with MarketBeat's FREE newsletter.

Amgen (NASDAQ:AMGN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202111,380,000 shares $2.37 billion +2.7%2.0%4.5 $207.84
9/30/202111,080,000 shares $2.36 billion -4.7%2.0%4.5 $212.65
9/15/202111,630,000 shares $2.54 billion +3.8%2.1%4.8 $218.13
8/31/202111,210,000 shares $2.53 billion -0.3%2.0%4.7 $225.53
8/13/202111,240,000 shares $2.58 billion +5.0%2.0%4.6 $229.68
7/30/202110,710,000 shares $2.59 billion +3.6%1.9%4.3 $241.54
7/15/202110,340,000 shares $2.55 billion +10.7%1.8%4 $246.63
6/30/20219,340,000 shares $2.28 billion -6.8%1.6%3.6 $243.75
6/15/202110,020,000 shares $2.40 billion -0.2%1.8%3.9 $239.85
5/28/202110,040,000 shares $2.39 billion -12.4%1.8%3.6 $237.94
5/14/202111,460,000 shares $2.89 billion +8.0%2.0%4.1 $252.07
4/30/202110,610,000 shares $2.49 billion -3.3%1.9%3.9 $234.71
4/15/202110,970,000 shares $2.74 billion -3.7%1.9%4.2 $249.62
3/31/202111,390,000 shares $2.84 billion +15.3%2.0%4.3 $249.75
3/15/20219,880,000 shares $2.28 billion +22.0%1.7%3.6 $230.36
2/26/20218,100,000 shares $1.84 billion -7.0%1.4%3.2 $227.52
2/12/20218,710,000 shares $2.05 billion +15.2%1.5%3.5 $235.04
1/29/20217,560,000 shares $1.87 billion +7.7%1.3%3 $247.75
1/15/20217,020,000 shares $1.70 billion +0.9%1.2%2.8 $241.66
12/31/20206,960,000 shares $1.58 billion +0.7%1.2%2.8 $227.17
12/15/20206,910,000 shares $1.59 billion +6.1%1.2%2.7 $229.46
11/30/20206,510,000 shares $1.46 billion -13.0%1.1%2.5 $224.81
11/15/20207,480,000 shares $1.78 billion +5.2%1.3%2.6 $237.36
10/30/20207,110,000 shares $1.55 billion +5.8%1.2%2.6 $217.82
10/15/20206,720,000 shares $1.60 billion +9.6%1.2%2.5 $237.65

Institutional Investors Shorting Amgen (NASDAQ:AMGN)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Amgen. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
10/21/2021V Wealth Advisors LLCN/A400N/A$85.00
10/19/2021SpiderRock Advisors LLC7,8005,300-32.1%$926.00
9/13/2021Bank of America Corp DE228,300339,500+48.7%$82,753.00
8/31/2021Pathstone Family Office LLCN/A4,295N/A$1,047.00
8/17/2021Wells Fargo & Company MNN/A25,000N/A$6,094.00
8/17/2021Walleye Trading LLC15,30010,500-31.4%$2,559.00
8/17/2021Logan Capital Management Inc.N/A12,369N/A$3,015.00
8/17/2021Millennium Management LLC590,800492,000-16.7%$119,925.00
8/17/2021Pathstone Family Office LLCN/A4,295N/A$1,047.00
8/17/2021Parallax Volatility Advisers L.P.N/A200N/A$48.00
8/17/2021Balyasny Asset Management LLCN/A6,100N/A$1,487.00
8/17/2021Caas Capital Management LP7,5000-100.0%$0.00
8/17/2021Citadel Advisors LLC527,600579,800+9.9%$141,326.00
8/16/2021Squarepoint Ops LLC69,40017,800-74.4%$4,339.00
8/16/2021Bank of America Corp DE228,300339,500+48.7%$82,753.00
8/16/2021SG3 Management LLC81,50085,000+4.3%$20,719.00
8/16/2021Credit Suisse AG100,80074,700-25.9%$18,208.00
8/16/2021Maven Securities LTD19,80013,800-30.3%$3,364.00
8/16/2021Capula Management Ltd172,00010,900-93.7%$2,657.00
8/16/2021Goldman Sachs Group Inc.96,80045,700-52.8%$11,139.00
8/16/2021Allianz Asset Management GmbH23,00020,200-12.2%$4,924.00
8/13/2021PEAK6 Investments LLC18,6006,243-66.4%$7,385.00
8/13/2021SpiderRock Advisors LLC7,8007,800No Change$1,368.00
8/12/2021Simplex Trading LLC545128,900+23,551.4%$31,419.00
8/12/2021JPMorgan Chase & Co.60,500408,400+575.0%$99,548.00
8/11/2021HAP Trading LLC12,60017,400+38.1%$121.00
8/11/2021Susquehanna International Group LLP803,0001,238,900+54.3%$301,982.00
8/10/2021BNP Paribas Arbitrage SA1,1561,062-8.1%$25,886.00
8/10/2021Citigroup Inc.99,300149,300+50.4%$36,392.00
8/6/2021Wolverine Trading LLC58,8000-100.0%$0.00
8/6/2021HighTower Advisors LLC191,600+8,321.1%$1.00
8/6/2021IMC Chicago LLC48,70031,400-35.5%$7,654.00
8/6/2021Gladius Capital Management LP84,3003,100-96.3%$756.00













Amgen (NASDAQ:AMGN) Short Interest Frequently Asked Questions

What is Amgen's current short interest?

Short interest is the volume of Amgen shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 11,380,000 shares of AMGN short. 2.01% of Amgen's shares are currently sold short. Learn More on Amgen's current short interest.

What is a good short interest ratio for Amgen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Amgen currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for Amgen

Which institutional investors are shorting Amgen?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: V Wealth Advisors LLC, SpiderRock Advisors LLC, Bank of America Corp DE, Pathstone Family Office LLC, Wells Fargo & Company MN, Walleye Trading LLC, Logan Capital Management Inc., Millennium Management LLC, Pathstone Family Office LLC, Parallax Volatility Advisers L.P., Balyasny Asset Management LLC, Caas Capital Management LP, Citadel Advisors LLC, Squarepoint Ops LLC, Bank of America Corp DE, SG3 Management LLC, Credit Suisse AG, Maven Securities LTD, Capula Management Ltd, Goldman Sachs Group Inc., Allianz Asset Management GmbH, PEAK6 Investments LLC, SpiderRock Advisors LLC, Simplex Trading LLC, JPMorgan Chase & Co., HAP Trading LLC, Susquehanna International Group LLP, BNP Paribas Arbitrage SA, Citigroup Inc., Wolverine Trading LLC, HighTower Advisors LLC, IMC Chicago LLC, and Gladius Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Amgen?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.01% of Amgen's floating shares are currently sold short.

Is Amgen's short interest increasing or decreasing?

Amgen saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 11,380,000 shares, an increase of 2.7% from the previous total of 11,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Amgen's float size?

Amgen currently has issued a total of 567,852,000 shares. Some of Amgen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amgen currently has a public float of 566,690,000 shares.

How does Amgen's short interest compare to its competitors?

2.01% of Amgen's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Amgen: Gilead Sciences, Inc. (0.00%), Regeneron Pharmaceuticals, Inc. (1.72%), Vertex Pharmaceuticals Incorporated (1.72%), Biogen Inc. (1.64%), Seagen Inc. (1.87%), Alnylam Pharmaceuticals, Inc. (0.00%), Exact Sciences Co. (0.00%), Repligen Co. (3.18%), Incyte Co. (2.32%), and BioMarin Pharmaceutical Inc. (5.90%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.75 billion), S&P Global Inc. ($7.73 billion), Charter Communications, Inc. ($5.40 billion), Snowflake Inc. ($4.50 billion), Canadian Pacific Railway Limited ($4.39 billion), Uber Technologies, Inc. ($4.21 billion), Wayfair Inc. ($4.15 billion), Palo Alto Networks, Inc. ($3.27 billion), Teladoc Health, Inc. ($2.78 billion), and DoorDash, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Amgen stock?

Short selling AMGN is an investing strategy that aims to generate trading profit from Amgen as its price is falling. Amgen's stock is trading down $2.10 today. To short Amgen stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Amgen will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amgen?

A short squeeze for Amgen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMGN, which in turn drives the price of the stock up even further.

How often is Amgen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMGN, twice per month. The most recent reporting period available is October, 15 2021.



This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.